Literature DB >> 9614824

Bioethics for clinicians: 14. Ethics and genetics in medicine.

M M Burgess1, C M Laberge, B M Knoppers.   

Abstract

Information about a patient's inherited risk of disease has important ethical and legal implications in clinical practice. Because genetic information is by nature highly personal yet familial, issues of confidentiality arise. Counselling and informed consent before testing are important in view of the social and psychological risks that accompany testing, the complexity of information surrounding testing, and the fact that effective interventions are often not available. Follow-up counselling is also important to help patients integrate test results into their lives and the lives of their relatives. Genetic counselling should be provided by practitioners who have up-to-date knowledge of the genetics of and the tests available for specific diseases, are aware of the social and psychological risks associated with testing, and are able to provide appropriate clinical follow-up. Some physicians may elect to refer patients for genetic counselling and testing. However, it is inevitable that all physicians will be involved in long-term follow-up both by monitoring for disease and by supporting the integration of genetic information into patients' lives.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Year:  1998        PMID: 9614824      PMCID: PMC1229325     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  19 in total

1.  Professional perspectives: a survey of Canadian providers.

Authors:  D C Wertz
Journal:  Health Law J       Date:  1995

2.  Structuring the review of human genetics protocols, Part II: diagnostic and screening studies.

Authors:  Kathleen Cranley Glass; Charles Weijer; Trudo Lemmens; Roberta M Palmour; Stanley H Shapiro
Journal:  IRB       Date:  1997 May-Aug

3.  Genetic testing for Huntington's disease--a family issue.

Authors:  C V Hayes
Journal:  N Engl J Med       Date:  1992-11-12       Impact factor: 91.245

4.  A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.

Authors:  B Kremer; P Goldberg; S E Andrew; J Theilmann; H Telenius; J Zeisler; F Squitieri; B Lin; A Bassett; E Almqvist
Journal:  N Engl J Med       Date:  1994-05-19       Impact factor: 91.245

5.  DNA sampling and informed consent.

Authors:  B M Knoppers; C Laberge
Journal:  CMAJ       Date:  1989-05-01       Impact factor: 8.262

6.  Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.

Authors:  I M van der Steenstraten; A Tibben; R A Roos; J J van de Kamp; M F Niermeijer
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

7.  Proceed with care: direct predictive testing for Huntington disease.

Authors:  C M Benjamin; S Adam; S Wiggins; J L Theilmann; T T Copley; M Bloch; F Squitieri; W McKellin; S Cox; S A Brown
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

8.  Psychological costs and benefits of predictive testing for Huntington's disease.

Authors:  A M Codori; J Brandt
Journal:  Am J Med Genet       Date:  1994-09-15

9.  Ethical issues in genetic testing for Alzheimer's disease: lessons from Huntington's disease.

Authors:  M M Burgess
Journal:  Alzheimer Dis Assoc Disord       Date:  1994       Impact factor: 2.703

10.  Social system responses to Huntington disease.

Authors:  S Kessler; M Bloch
Journal:  Fam Process       Date:  1989-03
View more
  6 in total

1.  The very youngest science.

Authors:  Alison Sinclair; Judith Hall
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

2.  Conflict of interest in medical research in Estonia.

Authors:  Arvo Tikk
Journal:  Sci Eng Ethics       Date:  2002-07       Impact factor: 3.525

Review 3.  Ethical issues in molecular medicine of relevance to surgeons.

Authors:  Mark Bernstein; Joseph Bampoe; Abdallah S Daar
Journal:  Can J Surg       Date:  2004-12       Impact factor: 2.089

4.  The potential for misusing "genetic predisposition" in Canadian courts and tribunals.

Authors:  Roxanne Mykitiuk; Mark Pioro; Lilith Finkler; Jeff Nisker
Journal:  CMAJ       Date:  2011-05-24       Impact factor: 8.262

Review 5.  Attitudes of health care professionals toward pharmacogenetic testing.

Authors:  Nathalie K Zgheib; Thalia Arawi; Rami A Mahfouz; Ramzi Sabra
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

6.  The unique ethical challenges of conducting research in the rehabilitation medicine population.

Authors:  Jeff Blackmer
Journal:  BMC Med Ethics       Date:  2003-06-17       Impact factor: 2.652

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.